Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
Original Source
Read the full article at Sciencedaily →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.